AHFS/Drugs.com Monograph ATC code H01AC03 (WHO) CAS Number 68562-41-4 | Routes of
administration Subcutaneous Legal status US: ℞-only | |
Pregnancy
category US: C (Risk not ruled out) | ||
Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in children with severe primary IGF-I deficiency.
This drug is not to be confused with mecasermin rinfabate (trade name Iplex), which is a combination of recombinant human IGF-1 (rhIGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3). IGFBP-3 serves to prolong the action of IGF-1 in the human body.
References
Mecasermin Wikipedia(Text) CC BY-SA